EX-99.1
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Existing and pipeline oncology monoclonal antibody biosimilars. FDA =... | Download Scientific Diagram
Teva Pharmaceuticals (@TevaUSA) / X
Teva Pharmaceutical: Long-Term Cash Cow
A Look at Teva's Generic Drugs Research Pipeline
Teva Prepares To Launch LAI Risperidone After US Approval :: Generics Bulletin
Generic NSCLC treatment launched by Teva
Pharma News | Bristol Myers Squibb, Teva, MedinCell, Biogen
Teva sues FDA over bid to block approval of generic Copaxone | Mint
Teva's drug pipeline could contain blockbusters - Globes
Medincell stock drops as FDA hits Teva with CRL on long-acting risperidone | BioWorld
Top Biosimilar Companies with Approved and Pipeline Products in the US and EU
The Mighty Teva Pharmaceutical: Unveiling A Bullish Scenario You Must Consider (NYSE:TEVA) | Seeking Alpha
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson
Teva Pharmaceutical Industries Ltd (TEVA) - Product Pipeline Analysis, 2021 Update
Teva's migraine drug Ajovy secures European marketing approval
US FDA eases Teva headache with Ajovy approval
Teva obtains FDA nod for generic Forteo | Drug Store News
Non-Hodgkin Lymphoma Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | AstraZeneca, Baxter International Inc., Bayer AG, Bristol Myers Squibb, Teva Pharma, Eli Lilly, Roche – ABNewswire
ABNewswire on X: "Gene Therapies for Cardiomyopathies Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Novartis, Merck, Teva Pharma, Bristol Myers… https://t.co/fjnW8Jyv9b #Business #HealthMedicine ...
Teva Stock Dives After Inking $1.5 Billion Deal For Inflammation Drug | Investor's Business Daily
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Sosei see Teva pipeline cull as an opportunity | pharmaphorum
